These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38575077)

  • 1. Nanomodulators targeting endothelial WNT and pericytes to reversibly open the blood-tumor barrier for boosted brain tumor therapy.
    Mu R; Sun H; Zeng Y; Tong Y; Tang P; Zhao M; Lv Z; Yu J; Chen Y; Lan Q; Zhen X; Han L
    J Control Release; 2024 May; 369():458-474. PubMed ID: 38575077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Glioma Stem Cell-Derived Pericytes Disrupts the Blood-Tumor Barrier and Improves Chemotherapeutic Efficacy.
    Zhou W; Chen C; Shi Y; Wu Q; Gimple RC; Fang X; Huang Z; Zhai K; Ke SQ; Ping YF; Feng H; Rich JN; Yu JS; Bao S; Bian XW
    Cell Stem Cell; 2017 Nov; 21(5):591-603.e4. PubMed ID: 29100012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer.
    Lockman PR; Mittapalli RK; Taskar KS; Rudraraju V; Gril B; Bohn KA; Adkins CE; Roberts A; Thorsheim HR; Gaasch JA; Huang S; Palmieri D; Steeg PS; Smith QR
    Clin Cancer Res; 2010 Dec; 16(23):5664-78. PubMed ID: 20829328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting glioblastoma-derived pericytes improves chemotherapeutic outcome.
    Guerra DAP; Paiva AE; Sena IFG; Azevedo PO; Silva WN; Mintz A; Birbrair A
    Angiogenesis; 2018 Nov; 21(4):667-675. PubMed ID: 29761249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prodrug Delivery Using Dual-Targeting Nanoparticles To Treat Breast Cancer Brain Metastases.
    Ju X; Chen H; Miao T; Ni J; Han L
    Mol Pharm; 2021 Jul; 18(7):2694-2702. PubMed ID: 34109794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in Pericyte Subpopulations Are Associated with Elevated Blood-Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer.
    Lyle LT; Lockman PR; Adkins CE; Mohammad AS; Sechrest E; Hua E; Palmieri D; Liewehr DJ; Steinberg SM; Kloc W; Izycka-Swieszewska E; Duchnowska R; Nayyar N; Brastianos PK; Steeg PS; Gril B
    Clin Cancer Res; 2016 Nov; 22(21):5287-5299. PubMed ID: 27245829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRP1-upregulated nanoparticles for efficiently conquering the blood-brain barrier and targetedly suppressing multifocal and infiltrative brain metastases.
    Guo Q; Zhu Q; Miao T; Tao J; Ju X; Sun Z; Li H; Xu G; Chen H; Han L
    J Control Release; 2019 Jun; 303():117-129. PubMed ID: 31026546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvianolic acid A increases the accumulation of doxorubicin in brain tumors through Caveolae endocytosis.
    Zhang C; Pan Y; Cai R; Guo S; Zhang X; Xue Y; Wang J; Huang J; Wang J; Gu Y; Zhang Z
    Neuropharmacology; 2020 May; 167():107980. PubMed ID: 32014448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood-tumor barrier disruption.
    Arvanitis CD; Askoxylakis V; Guo Y; Datta M; Kloepper J; Ferraro GB; Bernabeu MO; Fukumura D; McDannold N; Jain RK
    Proc Natl Acad Sci U S A; 2018 Sep; 115(37):E8717-E8726. PubMed ID: 30150398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles Containing a Combination of a Drug and an Antibody for the Treatment of Breast Cancer Brain Metastases.
    Wyatt EA; Davis ME
    Mol Pharm; 2020 Feb; 17(2):717-721. PubMed ID: 31916770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF-mediated tight junctions pathological fenestration enhances doxorubicin-loaded glycolipid-like nanoparticles traversing BBB for glioblastoma-targeting therapy.
    Wen L; Tan Y; Dai S; Zhu Y; Meng T; Yang X; Liu Y; Liu X; Yuan H; Hu F
    Drug Deliv; 2017 Nov; 24(1):1843-1855. PubMed ID: 29182025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model.
    Park EJ; Zhang YZ; Vykhodtseva N; McDannold N
    J Control Release; 2012 Nov; 163(3):277-84. PubMed ID: 23000189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting microbubbles-carrying TGFβ1 inhibitor combined with ultrasound sonication induce BBB/BTB disruption to enhance nanomedicine treatment for brain tumors.
    Chen YC; Chiang CF; Wu SK; Chen LF; Hsieh WY; Lin WL
    J Control Release; 2015 Aug; 211():53-62. PubMed ID: 26047759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
    Khaitan D; Reddy PL; Ningaraj N
    Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PSMA-targeted nanoparticles for specific penetration of blood-brain tumor barrier and combined therapy of brain metastases.
    Ni J; Miao T; Su M; Khan NU; Ju X; Chen H; Liu F; Han L
    J Control Release; 2021 Jan; 329():934-947. PubMed ID: 33069744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
    Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
    J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors.
    Byeon HJ; Thao le Q; Lee S; Min SY; Lee ES; Shin BS; Choi HG; Youn YS
    J Control Release; 2016 Mar; 225():301-13. PubMed ID: 26826308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressing Wnt signaling of the blood‒tumor barrier to intensify drug delivery and inhibit lipogenesis of brain metastases.
    Tong Y; An P; Tang P; Mu R; Zeng Y; Sun H; Zhao M; Lv Z; Wang P; Han W; Gui C; Zhen X; Han L
    Acta Pharm Sin B; 2024 Jun; 14(6):2716-2731. PubMed ID: 38828148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous targeting of peripheral and brain tumors with a therapeutic nanoparticle to disrupt metabolic adaptability at both sites.
    Ashokan A; Sarkar S; Kamran MZ; Surnar B; Kalathil AA; Spencer A; Dhar S
    Proc Natl Acad Sci U S A; 2024 May; 121(20):e2318119121. PubMed ID: 38709930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lnc00462717 regulates the permeability of the blood-brain tumor barrier through interaction with PTBP1 to inhibit the miR-186-5p/Occludin signaling pathway.
    Zhang C; Zhang X; Wang J; Di F; Xue Y; Lin X; Zhang Y; Zhang H; Zhang Z; Gu Y
    FASEB J; 2020 Aug; 34(8):9941-9958. PubMed ID: 32623796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.